Zobrazeno 1 - 10
of 1 489
pro vyhledávání: '"Welm AL"'
Autor:
Besse A; Laboratory of Experimental Oncology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, 9000, Switzerland.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, 62500, Czech Republic., Sedlarikova L; Babak Myeloma Group, Department of Pathological Physiology, Masaryk University, Brno, 62500, Czech Republic.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, 62500, Czech Republic., Buechler L; Laboratory of Experimental Oncology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, 9000, Switzerland., Kraus M; Laboratory of Experimental Oncology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, 9000, Switzerland., Yang CH; Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Strakova N; Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, 612 00, Czech Republic.; Veterinary Research Institute, Brno, 62500, Czech Republic., Soucek K; Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, 612 00, Czech Republic.; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic., Navratil J; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, 62500, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, 62500, Czech Republic., Svoboda M; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, 62500, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, 62500, Czech Republic., Welm AL; Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Joerger M; Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, 9000, Switzerland., Driessen C; Laboratory of Experimental Oncology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, 9000, Switzerland.; Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, 9000, Switzerland., Besse L; Laboratory of Experimental Oncology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, 9000, Switzerland. Lenka.besse@kssg.ch.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, 62500, Czech Republic. Lenka.besse@kssg.ch.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Sep; Vol. 131 (5), pp. 918-930. Date of Electronic Publication: 2024 Jul 05.
Autor:
White BS; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut., Woo XY; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut.; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Koc S; Velsera, Charlestown, Massachusetts., Sheridan T; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut., Neuhauser SB; The Jackson Laboratory, Bar Harbor, Maine., Wang S; University of Texas Southwestern Medical Center, Dallas, Texas., Evrard YA; Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Chen L; Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Foroughi Pour A; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut., Landua JD; Baylor College of Medicine, Houston, Texas., Mashl RJ; Washington University School of Medicine, St. Louis, Missouri., Davies SR; Washington University School of Medicine, St. Louis, Missouri., Fang B; University of Texas MD Anderson Cancer Center, Houston, Texas., Raso MG; University of Texas MD Anderson Cancer Center, Houston, Texas., Evans KW; University of Texas MD Anderson Cancer Center, Houston, Texas., Bailey MH; Simmons Center for Cancer Research, Brigham Young University, Provo, Utah., Chen Y; The Wistar Institute, Philadelphia, Pennsylvania., Xiao M; The Wistar Institute, Philadelphia, Pennsylvania., Rubinstein JC; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut., Sanderson BJ; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut., Lloyd MW; The Jackson Laboratory, Bar Harbor, Maine., Domanskyi S; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut., Dobrolecki LE; Baylor College of Medicine, Houston, Texas., Fujita M; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Fujimoto J; University of Texas MD Anderson Cancer Center, Houston, Texas., Xiao G; University of Texas Southwestern Medical Center, Dallas, Texas., Fields RC; Washington University School of Medicine, St. Louis, Missouri., Mudd JL; Washington University School of Medicine, St. Louis, Missouri., Xu X; The Wistar Institute, Philadelphia, Pennsylvania., Hollingshead MG; National Cancer Institute, Bethesda, Maryland., Jiwani S; Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Acevedo S; Velsera, Charlestown, Massachusetts., Davis-Dusenbery BN; Velsera, Charlestown, Massachusetts., Robinson PN; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut., Moscow JA; National Cancer Institute, Bethesda, Maryland., Doroshow JH; National Cancer Institute, Bethesda, Maryland., Mitsiades N; Baylor College of Medicine, Houston, Texas., Kaochar S; Baylor College of Medicine, Houston, Texas., Pan CX; University of California, Davis, Davis, California., Carvajal-Carmona LG; University of California, Davis, Davis, California., Welm AL; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Welm BE; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Govindan R; Washington University School of Medicine, St. Louis, Missouri., Li S; Washington University School of Medicine, St. Louis, Missouri., Davies MA; University of Texas MD Anderson Cancer Center, Houston, Texas., Roth JA; University of Texas MD Anderson Cancer Center, Houston, Texas., Meric-Bernstam F; University of Texas MD Anderson Cancer Center, Houston, Texas., Xie Y; University of Texas Southwestern Medical Center, Dallas, Texas., Herlyn M; The Wistar Institute, Philadelphia, Pennsylvania., Ding L; Washington University School of Medicine, St. Louis, Missouri., Lewis MT; Baylor College of Medicine, Houston, Texas., Bult CJ; The Jackson Laboratory, Bar Harbor, Maine., Dean DA 2nd; Velsera, Charlestown, Massachusetts., Chuang JH; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut.
Publikováno v:
Cancer research [Cancer Res] 2024 Jul 02; Vol. 84 (13), pp. 2060-2072.
Autor:
Vaklavas C; Department of Internal Medicine, Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Matsen CB; Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Chu Z; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Boucher KM; Department of Internal Medicine, Division of Epidemiology, Salt Lake City, UT., Scherer SD; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Pathi S; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Beck A; Department of Internal Medicine, Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Brownson KE; Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Buys SS; Department of Internal Medicine, Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Chittoria N; Department of Internal Medicine, Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., D'Astous E; Huntsman Cancer Institute Clinical Trials Office, Salt Lake City, UT., Gulbahce HE; Department of Pathology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Henry NL; Department of Internal Medicine, Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.; Current Address: Department of Internal Medicine, University of Michigan, Ann Arbor, MI., Kimani S; Department of Internal Medicine, Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Porretta J; Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Rosenthal R; Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Ward J; Department of Internal Medicine, Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Wei M; Department of Internal Medicine, Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Welm BE; Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Welm AL; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Jul; Vol. 8, pp. e2300724.
Autor:
Geukens T; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Maetens M; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Hooper JE; Stanford University School of Medicine, Palo Alto, CA, USA., Oesterreich S; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Lee AV; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Miller L; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Atkinson JM; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Rosenzweig M; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Puhalla S; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Thorne H; Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Devereux L; Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Bowtell D; Peter MacCallum Cancer Centre, Melbourne, Australia., Loi S; Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Bacon ER; Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA., Ihle K; Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA., Song M; Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA., Rodriguez-Rodriguez L; Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA., Welm AL; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Gauchay L; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Murali R; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chanda P; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Karacay A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Naceur-Lombardelli C; UCL Cancer Institute, University College London, London, UK., Bridger H; Cancer Research UK, and UCL Cancer Trials Centre, University College London, London, UK., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Kollath L; University of Washington, Seattle, WA, USA., True L; University of Washington, Seattle, WA, USA., Morrissey C; University of Washington, Seattle, WA, USA., Chambers M; University of Washington, Seattle, WA, USA., Chinnaiyan AM; University of Michigan, Ann Arbor, MI, USA., Wilson A; University of Michigan, Ann Arbor, MI, USA., Mehra R; University of Michigan, Ann Arbor, MI, USA., Reichert Z; University of Michigan, Ann Arbor, MI, USA., Carey LA; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Perou CM; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Kelly E; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Maeda D; Department of Molecular and Cellular Pathology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan., Goto A; Department of Cellular and Organ Pathology, Graduate School of Medicine, Akita University, Akita, Japan., Kulka J; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary., Székely B; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.; National Institute of Oncology, Budapest, Hungary., Szasz AM; Division of Oncology, Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary., Tőkés AM; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary., Van Den Bogaert W; Department of Forensic Medicine, University Hospitals Leuven, Leuven, Belgium., Floris G; Department of Pathology, University Hospitals Leuven, Leuven, Belgium., Desmedt C; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
Publikováno v:
The Journal of pathology [J Pathol] 2024 Jun; Vol. 263 (2), pp. 150-165. Date of Electronic Publication: 2024 Mar 29.
Autor:
Quail DF; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec H3A 1A3, Canada.; Department of Physiology, McGill University, Montreal, Quebec H3G 1Y6, Canada., Park M; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec H3A 1A3, Canada.; Departments of Biochemistry, Oncology, McGill University, Montreal, Quebec H3G 1Y6, Canada., Welm AL; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA., Ekiz HA; Department of Molecular Biology and Genetics, Izmir Institute of Technology, Gulbahce, 35430 Urla, Izmir, Turkey atakanekiz@iyte.edu.tr.
Publikováno v:
Cold Spring Harbor perspectives in medicine [Cold Spring Harb Perspect Med] 2024 Feb 01; Vol. 14 (2). Date of Electronic Publication: 2024 Feb 01.
Autor:
Goddard ET; Public Health Sciences Division/Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Linde MH; Public Health Sciences Division/Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Center for Metastasis Research eXcellence (MET-X), Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Srivastava S; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Center for Metastasis Research eXcellence (MET-X), Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Klug G; Public Health Sciences Division/Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Shabaneh TB; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Iannone S; Public Health Sciences Division/Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Center for Metastasis Research eXcellence (MET-X), Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Grzelak CA; Public Health Sciences Division/Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Center for Metastasis Research eXcellence (MET-X), Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Marsh S; Public Health Sciences Division/Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Center for Metastasis Research eXcellence (MET-X), Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Riggio AI; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA., Shor RE; Public Health Sciences Division/Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Linde IL; Public Health Sciences Division/Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Center for Metastasis Research eXcellence (MET-X), Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Guerrero M; Public Health Sciences Division/Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Veatch JR; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Snyder AG; Public Health Sciences Division/Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Center for Metastasis Research eXcellence (MET-X), Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Welm AL; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA., Riddell SR; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Center for Metastasis Research eXcellence (MET-X), Fred Hutchinson Cancer Center, Seattle, WA 98109, USA. Electronic address: sriddell@fredhutch.org., Ghajar CM; Public Health Sciences Division/Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Center for Metastasis Research eXcellence (MET-X), Fred Hutchinson Cancer Center, Seattle, WA 98109, USA. Electronic address: cghajar@fredhutch.org.
Publikováno v:
Cancer cell [Cancer Cell] 2024 Jan 08; Vol. 42 (1), pp. 119-134.e12.
Autor:
Wu Y; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, Missouri., Chen S; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, Missouri., Yang X; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri., Sato K; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, Missouri., Lal P; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri., Wang Y; Department of Pathology, Johns Hopkins University, Baltimore, Maryland., Shinkle AT; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri., Wendl MC; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, Missouri.; Department of Genetics, Washington University in St. Louis, St. Louis, Missouri.; McKelvey School of Engineering, Washington University in St. Louis, St. Louis, Missouri., Primeau TM; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri., Zhao Y; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri., Gould A; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri., Sun H; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, Missouri., Mudd JL; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri., Hoog J; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri., Mashl RJ; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, Missouri., Wyczalkowski MA; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, Missouri., Mo CK; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, Missouri., Liu R; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, Missouri., Herndon JM; Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri.; Department of Surgery, Washington University in St. Louis, St. Louis, Missouri., Davies SR; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri., Liu D; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri., Ding X; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri., Evrard YA; Frederick National Laboratory for Cancer Research, Frederick, Maryland., Welm BE; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Lum D; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Koh MY; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Welm AL; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Chuang JH; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut., Moscow JA; Investigational Drug Branch, National Cancer Institute, Bethesda, Maryland., Meric-Bernstam F; The University of Texas MD Anderson Cancer Center, Houston, Texas., Govindan R; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; Department of Genetics, Washington University in St. Louis, St. Louis, Missouri., Li S; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; Department of Genetics, Washington University in St. Louis, St. Louis, Missouri., Hsieh J; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri., Fields RC; Department of Genetics, Washington University in St. Louis, St. Louis, Missouri., Lim KH; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; Department of Genetics, Washington University in St. Louis, St. Louis, Missouri., Ma CX; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; Department of Genetics, Washington University in St. Louis, St. Louis, Missouri., Zhang H; Department of Pathology, Johns Hopkins University, Baltimore, Maryland., Ding L; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, Missouri.; Department of Genetics, Washington University in St. Louis, St. Louis, Missouri.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri., Chen F; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.; Department of Genetics, Washington University in St. Louis, St. Louis, Missouri.
Publikováno v:
Cancer research [Cancer Res] 2023 Dec 15; Vol. 83 (24), pp. 4161-4178.
Autor:
Cannon-Albright LA; Genetic Epidemiology Group, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.; George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148, USA.; Huntsman Cancer Institute, Salt Lake City, UT 84132, USA., Stevens J; Genetic Epidemiology Group, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA., Teerlink CC; Genetic Epidemiology Group, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.; George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148, USA., Facelli JC; Department of Biomedical Informatics and Utah Clinical and Translational Science Institute, University of Utah School of Medicine, Salt Lake City, UT 84132, USA., Allen-Brady K; Genetic Epidemiology Group, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA., Welm AL; Huntsman Cancer Institute, Salt Lake City, UT 84132, USA.; Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Dec 15; Vol. 15 (24). Date of Electronic Publication: 2023 Dec 15.
Autor:
Hermida-Prado F; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; University of Oviedo, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), IUOPA, Oviedo, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Xie Y; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Sherman S; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Nagy Z; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Russo D; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Akhshi T; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Chu Z; Huntsman Cancer Institute, Department of Oncological Sciences, University of Utah, Salt Lake City, Utah., Feit A; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Campisi M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Chen M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Nardone A; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Guarducci C; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lim K; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Font-Tello A; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Lee I; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., García-Pedrero J; University of Oviedo, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), IUOPA, Oviedo, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Cañadas I; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Agudo J; Harvard Medical School, Boston, Massachusetts.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Huang Y; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Sella T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts., Jin Q; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Tayob N; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Mittendorf EA; Harvard Medical School, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts., Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Long H; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Symmans WF; Department of Pathology, MD Anderson Cancer Center, Houston, Texas., Lin JR; Ludwig Center at Harvard and Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts.; Department of Systems Biology, Harvard Medical School, Boston, Massachusetts., Santagata S; Ludwig Center at Harvard and Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts.; Department of Systems Biology, Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Bedrosian I; Department of Breast Surgical Oncology, Division of Surgery, MD Anderson Cancer Center, Houston, Texas., Yardley DA; Department of Medical Oncology, Sarah Cannon Cancer Center, Nashville, Tennessee.; Tennessee Oncology, Nashville, Tennessee., Mayer IA; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Richardson ET; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Wu CJ; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Schuster EF; The BC Now Toby Robins Research Centre at the Institute of Cancer Research, London, United Kingdom.; Ralph Lauren Centre for BC Research, Royal Marsden Hospital, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Dowsett M; The BC Now Toby Robins Research Centre at the Institute of Cancer Research, London, United Kingdom.; Ralph Lauren Centre for BC Research, Royal Marsden Hospital, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Welm AL; Huntsman Cancer Institute, Department of Oncological Sciences, University of Utah, Salt Lake City, Utah., Barbie D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Metzger O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts., Jeselsohn R; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.
Publikováno v:
Cancer research [Cancer Res] 2023 Oct 02; Vol. 83 (19), pp. 3284-3304.
Autor:
Scherer SD; Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA; Department of Oncological Sciences, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA., Zhao L; Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA; Department of Oncological Sciences, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA., Butterfield AJ; Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA; Department of Oncological Sciences, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA., Yang CH; Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA; Department of Oncological Sciences, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA., Cortes-Sanchez E; Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA; Department of Oncological Sciences, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA., Guillen KP; Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA; Department of Oncological Sciences, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA., Welm BE; Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA; Department of Surgery, University of Utah, 30 N 1900 E, Salt Lake City, UT 84132, USA. Electronic address: bryan.welm@hci.utah.edu., Welm AL; Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA; Department of Oncological Sciences, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA. Electronic address: alana.welm@hci.utah.edu.
Publikováno v:
STAR protocols [STAR Protoc] 2023 Sep 15; Vol. 4 (3), pp. 102402. Date of Electronic Publication: 2023 Jul 03.